Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,520 | -4,602 | -4,514 | -82,667 | -19,667 |
| Depreciation Amortization | 9,410 | 4,121 | 2,063 | 76,407 | 10,643 |
| Income taxes - deferred | 26 | 210 | 193 | -6,327 | -4,484 |
| Accounts receivable | 6,638 | 1,859 | 3,624 | -1,305 | -201 |
| Accounts payable and accrued liabilities | -2,385 | 549 | 401 | -11 | -1,319 |
| Other Working Capital | -10,729 | -12,221 | -4,179 | -12,123 | -9,512 |
| Other Operating Activity | 35,381 | 8,889 | 2,286 | 24,238 | 19,114 |
| Operating Cash Flow | $3,821 | $-1,195 | $-126 | $-1,788 | $-5,426 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,427 | -5,211 | -1,808 | -5,427 | -3,587 |
| Purchase Sale Intangibles | -600 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -600 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-7,027 | $-5,211 | $-1,808 | $-5,427 | $-3,587 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 76 | 76 | 23 | 23 | 37 |
| Common Stock Repurchased | -5,339 | -1,370 | N/A | -5,000 | -5,000 |
| Other Financing Activity | -2,112 | -2,090 | -2,296 | -1,347 | -1,703 |
| Financing Cash Flow | $-7,375 | $-3,384 | $-2,273 | $-6,324 | $-6,666 |
| Exchange Rate Effect | 82 | -255 | -31 | 79 | 3 |
| Beginning Cash Position | 72,867 | 72,867 | 72,867 | 86,327 | 86,327 |
| End Cash Position | 62,368 | 62,822 | 68,629 | 72,867 | 70,651 |
| Net Cash Flow | $-10,499 | $-10,045 | $-4,238 | $-13,460 | $-15,676 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,821 | -1,195 | -126 | -1,788 | -5,426 |
| Capital Expenditure | -6,427 | -5,211 | -1,808 | -5,427 | -3,587 |
| Free Cash Flow | -2,606 | -6,406 | -1,934 | -7,215 | -9,013 |